Author

T Clark

Observed names: T. Clark, Tracy M. Clark

Institution: Pfizer (United States)

Observed institutions: The University of Texas at San Antonio Health Science Center, Pfizer (United States)

OpenAlex ID: A5109339663

Mechanistic Projection of First‐in‐Human Dose for Bispecific Immunomodulatory P‐Cadherin LP‐DART: An Integrated PK/PD Modeling Approach

2016 · X Chen, N Haddish‐Berhane, et al. · Clinical Pharmacology & Therapeutics · 51

Antihyperalgesic activity of epibatidine in the formalin model of facial pain

2001 · Shawn D. Gilbert, Tracy M. Clark, et al. · Pain · 46

Discovery and development of CP-724714, a selective HER2 receptor tyrosine kinase inhibitor

2004 · J. Jani, E. Barbacci, et al. · Journal of Clinical Oncology · 4

Discovery of new auristatins for the use on antibody drug conjugates for the treatment of cancer

2013 · Andreas Maderna, M Doroski, et al. · Abstracts of papers - American Chemical Society · 1

MEDI 340-Design, synthesis and evaluation of a potent class of spiroindoline pyrrolopyrimidines targeting Akt as anticancer agents

2007 · Goss S. Kauffman, Joel T. Arcari, et al. · Abstracts of papers - American Chemical Society

Works count: 5

Citation count: 102

H-index: 3

I10-index: 2